Lv1
90 积分 2024-09-12 加入
Case Report: A patient with the rare third-generation TKI-resistant mutation EGFR L718Q who responded to afatinib plus cetuximab combination therapy
18天前
已完结
Double-dose firmonertinib (formerly furmonertinib) for untreated EGFR-mutated non-small-cell lung cancer with brain metastases
28天前
已关闭
First-line sacituzumab tirumotecan with tagitanlimab in advanced non-small-cell lung cancer: a phase 2 trial
6个月前
已完结
First-line sacituzumab tirumotecan with tagitanlimab in advanced non-small-cell lung cancer: a phase 2 trial
6个月前
已完结
皖公网安备34019202002308
